Xenia Gonda

Dr. Xenia Gonda

Semmelweis University
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2019 in Medicina
Verified
Journal Article
Open access
PDF file
PDPeter Dome
Peter Dome
ZRZoltan Rihmer
Zoltan Rihmer
Xenia GondaXenia Gonda
Xenia Gonda
Bipolar disorders (BDs) are prevalent mental health illnesses that affect about 1–5% of the total population, have a chronic course and are associated with a markedly elevated premature mortality. One of the contributors for the decreased life expectancy in BD is suicide. Accordingly, the rate of suicide among BD patients is approximately 10–30 times higher than the corresponding rate in the general population. Extant research found that up to 20% of (mostly untreated) BD subjects end their life by suicide, and 20–60% of them attempt suicide at least one in their lifetime. In our paper we briefly recapitulate the current knowledge on the epidemiological aspects of suicide in BD as well as factors associated with suicidal risk in BD. Furthermore, we also discuss concisely the possible means of suicide prevention in BD.

1 December 2012 in Journal of Affective Disorders
Verified
Journal Article
Closed access
Xenia GondaXenia Gonda
Xenia Gonda
Maurizio PompiliMaurizio Pompili
Maurizio Pompili
Gianluca SerafiniGianluca Serafini
Gianluca Serafini
FMFranco Montebovi
Franco Montebovi
SCSandra Campi
Sandra Campi
ZRZoltan Rihmer
Zoltan Rihmer

22 September 2015 in Annals of General Psychiatry
Verified
Journal Article
Open access
PDF file
Xenia GondaXenia Gonda
Xenia Gonda
Maurizio PompiliMaurizio Pompili
Maurizio Pompili
Gianluca SerafiniGianluca Serafini
Gianluca Serafini
Andre CarvalhoAndre Carvalho
Andre Carvalho
ZRZoltan Rihmer
Zoltan Rihmer
PDPeter Dome
Peter Dome
The disability and burden associated with major depression comes only in part from its affective symptoms; cognitive dysfunctions associated with depression also play a crucial role. Furthermore, these cognitive impairments during depression are manifold and multilevel affecting elementary and more complex cognitive processes equally. Several models from different directions tried to evaluate, conceptualize and understand the depth and magnitude of cognitive dysfunctions in depression and their bidirectional interactions with other types of depressive symptomatology including mood symptoms. In the current review, we briefly overview different types of cognitive symptoms and deficits related to major depression including hot and cold as well as trait- and state-like cognitive alterations and we also describe current knowledge related to the impact of cognitive impairments on the course and outcomes of depression including remission, residual symptoms, function, and response to treatment. We also emphasize shortcomings of currently available treatments for depression in sufficiently improving cognitive dysfunctions and point out the need for newer pharmacological approaches especially in cooperation with psychotherapeutic interventions.

29 November 2024 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
VOVincenzo Oliva
Vincenzo Oliva
GFGiovanna Fico
Giovanna Fico
MPMichele De Prisco
Michele De Prisco
Xenia GondaXenia Gonda
Xenia Gonda
ARAdriane R. Rosa
Adriane R. Rosa
Eduard VietaEduard Vieta
Eduard Vieta
Bipolar disorders are chronic psychiatric conditions characterized by recurrent episodes of mania and depression. Affecting over 1% of the global population, these disorders contribute significantly to disability and mortality, often due to suicide and cardiovascular disease. Diagnostic challenges arise from symptom overlap with unipolar depression, frequently leading to delays. Bipolar disorders are driven by complex genetic, neurobiological, and environmental factors and are commonly accompanied by psychiatric and medical comorbidities, further complicating diagnosis and treatment. Standard management strategies include mood stabilizers, antipsychotics, and selective use of antidepressants, complemented by psychosocial interventions like cognitive-behavioral therapy and psychoeducation, which are vital for relapse prevention. Despite recent advancements, the management of bipolar disorders remains challenging, constrained by clinical variability, an absence of specific biomarkers, and differences in approved treatments and treatment guidelines across regions. Emerging research underscores the potential of precision psychiatry and digital health tools to enhance diagnosis and treatment. Nonetheless, critical gaps persist, particularly in implementing equitable care worldwide. This review offers a comprehensive update on bipolar disorders, examining clinical presentation, early diagnosis, pathogenesis, therapeutic strategies, and future perspectives to guide clinicians and researchers in addressing these ongoing challenges in research and clinical practice. None.

15 October 2021 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
Konstantinos N FountoulakisKonstantinos N Fountoulakis
Konstantinos N Fountoulakis
GKGrigorios Karakatsoulis
Grigorios Karakatsoulis
SASeri Abraham
Seri Abraham
KAKristina Adorjan
Kristina Adorjan
HAHelal Uddin Ahmed
Helal Uddin Ahmed
DSDaria Smirnova
Daria Smirnova

19 September 2008 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
Xenia GondaXenia Gonda
Xenia Gonda
KFKonstantinos N. Fountoulakis
Konstantinos N. Fountoulakis
GJGabriella Juhasz
Gabriella Juhasz
ZRZoltan Rihmer
Zoltan Rihmer
JLJudit Lazary
Judit Lazary
GBGyörgy Bagdy
György Bagdy